| Tue, Nov 3, 2009 | | • | Cramer Finds Catalyst for Celgene's Stock
at CNBC (Tue, Nov 3)
| | • | Cramer's 'Mad Money' Recap: The Only Sectors That Matter (Final)
at TheStreet.com (Tue, Nov 3)
| | • | Cramer's 'Mad Money' Recap: The Only Sectors That Matter (Update 3)
at TheStreet.com (Tue, Nov 3)
| | • | [video] Battling Cancer
at CNBC (Tue, Nov 3)
| | Fri, Oct 30, 2009 | | • | CELGENE CORP /DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Oct 30)
| | • | Spo Advisory Buys $9.5M Worth of Resolute Energy
TheStreet.com (Fri, Oct 30)
| | • | Celgene Corporation to Present at the Oppenheimer & Co. Inc. 20th Annual Healthcare Conference
Business Wire (Fri, Oct 30)
| | Tue, Oct 27, 2009 | | • | The Easiest Way to Become a Millionaire
at Motley Fool (Tue, Oct 27)
| | • | The Bull and Bear Story on GTx's Pending Drug Decision: BioBuzz
at TheStreet.com (Tue, Oct 27)
| | • | The Bull and Bear Story on GTx's Pending Drug Approval: BioBuzz
at TheStreet.com (Tue, Oct 27)
| | • | Big-Cap Biotech Worries Lead Sector Down: BioBuzz
at TheStreet.com (Tue, Oct 27)
| | Mon, Oct 26, 2009 | | • | Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues
Wall Street Transcript (Mon, Oct 26)
| | Fri, Oct 23, 2009 | | • | Not 50% Growth, but We'll Take It
at Motley Fool (Fri, Oct 23)
| | • | Global Healthcare Companies Investor 100% Overweighted To Biotech As Wave Of Acquisitions By Large Pharma Picks Up Pace
Wall Street Transcript (Fri, Oct 23)
| | Thu, Oct 22, 2009 | | • | Celgene 3Q profit surges on cancer drug sales
AP (Thu, Oct 22)
| | • | Should You Have Been in Bonds?
at Motley Fool (Thu, Oct 22)
| | • | CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
EDGAR Online (Thu, Oct 22)
| | • | Celgene earnings rise in quarter
at MarketWatch (Thu, Oct 22)
| | • | Celgene Reports Record Third Quarter 2009 Operating and Financial Results
Business Wire (Thu, Oct 22)
| | • | Q3 2009 Celgene Corp. Earnings Release - Time Not Supplied
CCBN (Thu, Oct 22)
| | Tue, Oct 20, 2009 | | • | Immunostimulatory Antibodies Seen As Potential Treatment For Broad Range Of Cancers And Catalyst For Investment Returns By Ladenburg Thalmann Analyst
Wall Street Transcript (Tue, Oct 20)
| | • | Trading Review for Cardium Therapeutics Inc. Issued by Beacon Equity
GlobeNewswire (Tue, Oct 20)
| | Mon, Oct 19, 2009 | | • | Updated Data from Randomized Controlled Phase II Study Evaluating Oral Apremilast in Psoriatic Arthritis Demonstrates Sustained Response at Six Months
Business Wire (Mon, Oct 19)
| | • | Stock Smackdown: Cramer vs. CAPS
at Motley Fool (Mon, Oct 19)
| | Wed, Oct 14, 2009 | | • | 5-Star Stocks Poised to Pop: KV Pharmaceutical
at Motley Fool (Wed, Oct 14)
|
Add CELG News to My Yahoo!:
 
| |
|
0.51% Nasdaq 
0.42 (0.74%) 
Headlines
